Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 10,111 shares at $73.35 ($743K) on 2026-05-01, disclosed to the SEC on 2026-05-05.
Scheduled sale ($743k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.35 | 8,680 | $637K | 85.7% |
| 2 | $74.45 | 1,431 | $107K | 14.3% |
| Total | $73.51 avg | 10,111 | $743K | 100% |
| Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |
| IONS | SELL | 2025-09-04 | $1.7M | — | Filing → |